15 results
6-K
CNTB
Connect Biopharma Holdings Limited
5 Sep 24
Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
4:20pm
)
Separately, the Group used the Black-Scholes option-pricing model to determine the fair value of ESPP compensation expense calculation
6-K
CNTB
Connect Biopharma Holdings Limited
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
the Binomial option-pricing model to determine the fair value of options as of the grant date. Separately, the Group used the Black-Scholes option
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Limited
5 Jun 23
Current report (foreign)
4:28pm
( 35.9) 20 (37.7) 20 (37.7) Race, n (%) White Asian Black/African American Not reported 0 39 (100.0) 0 0 5 (9.4) 48 (90.6) 0 0 4 (7.5) 46 (86.8) 1 (1.9
6-K
k7a crz4ijs
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
6-K
EX-99.2
67knxvnprai nyki
3 May 22
Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis
4:36pm
20-F
ukt qhf23f
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.2
ogf3f n4j0lshn
5 Jan 22
Current report (foreign)
5:24pm
424B4
iurq mbntw8
19 Mar 21
Prospectus supplement with pricing info
4:49pm
F-1/A
uxv0aj w3kb
18 Mar 21
Registration statement (foreign) (amended)
6:15am
F-1/A
w3i1r7bwzvn2vazosyx
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
033zcosd o3m
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
it37w4cpf6ihirxlnk2r
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
xos 4gex246z5pjvbibn
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next